Intajac 11mg Tablet ER

Overview Intajac 11mg Tablet ER

Rheumacin 11mg Extended-Release Tablets are indicated for managing moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation and helps retard the progression of bone and joint deterioration. Rheumacin 11mg ER may be administered alone or in conjunction with other therapies. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other medications. Strictly adhere to your physician's prescribed regimen. Discontinue use only under your doctor's guidance, as abrupt cessation could exacerbate your condition. Commonly reported side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events like blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment blood work may be required, and initiation of therapy is contraindicated in the presence of any infection. Prior to commencing treatment, discuss your medical history with your doctor, particularly if you have or have had tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Rheumacin 11mg ER can increase susceptibility to infections or worsen existing ones; avoid contact with contagious individuals (e.g., those with chickenpox, measles, influenza). This medication is unsuitable for individuals under 18 years of age and should not be used during pregnancy or breastfeeding unless the potential benefits outweigh the risks as determined by your physician. Regular monitoring by your doctor may be necessary.

Uses of Intajac 11mg Tablet ER

Managing rheumatoid, psoriatic, and ankylosing spondylitis, plus ulcerative colitis.

Major Benefits of Intajac 11mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Intajac 11mg Extended-Release Tablets can be consumed with or without food; however, consistent daily timing is recommended.

Common Side effects of Intajac 11mg Tablet ER:

• Upper respiratory tract infection
• Headache
• Diarrhea
• Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Intajac 11mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Intajac 11mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

How Intajac 11mg Tablet ER works:

Intajac 11mg Extended-Release tablets contain a Janus kinase inhibitor that suppresses Janus kinase enzyme activity. This, in turn, reduces immune system response and inflammation characteristic of rheumatic conditions and ulcerative colitis.

What if you forget to take Intajac 11mg Tablet ER :

Should you forget to take your Intajac 11mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.